An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism

BACKGROUND: Hypogonadotropic hypogonadism (HH) in men results in insufficient testicular function and deficiencies in testosterone and spermatogenesis. Combinations of human chorionic gonadotropin (hCG) and recombinant follicle-stimulating hormone (recFSH) have been successful in the treatment of HH...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieschlag, Eberhard, Bouloux, Pierre-Marc G., Stegmann, Barbara J., Shankar, R. Ravi, Guan, Yanfen, Tzontcheva, Anjela, McCrary Sisk, Christine, Behre, Hermann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341390/
https://www.ncbi.nlm.nih.gov/pubmed/28270212
http://dx.doi.org/10.1186/s12958-017-0232-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341390/
https://www.ncbi.nlm.nih.gov/pubmed/28270212
http://dx.doi.org/10.1186/s12958-017-0232-y

Ejemplares similares